GRADE Evidence Tables - Recommendations in MMWR
The following summarize GRADE (Grading of Recommendations, Assessment, Development and Evaluation) methods and evidence tables that accompany ACIP recommendations published in the Morbidity and Mortality Weekly Reports (MMWR).
This standardized and more explicit process for developing ACIP recommendations is expected to enhance transparency, consistency, and communication.
List of GRADE Materials and Evidence Tables
Listed in most recently published order.
- Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine
Linked from MMWR; December 13, 2020 / 69 - Use of MenACWY-TT (MenQuadfi) as an option for meningococcal serogroup A, C, W, and Y (MenACWY) vaccination
Linked from MMWR; September 25 / 69(9);1–41 - Use of Serogroup B Meningococcal (MenB) vaccines for persons at increased risk for serogroup B meningococcal disease
Linked from MMWR; September 25 / 69(9);1–41 - Use of Hepatitis A Vaccine for Persons With HIV
Linked from MMWR; July 3, 2020 / 69(5);1–38 - Use of PCV13 among adults ≥65 years old
Linked from MMWR; November 22, 2019 / 68(46) - Use of HPV Vaccine in Adults, Ages 27 through 45 years
Linked from MMWR; August 16, 2019 / 68(32);698-702 - Use of Japanese Encephalitis Vaccine
Linked from MMWR; July 19, 2019 / 68(2);1–33 - Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
Linked from MMWR; February 15, 2019 / 68(6);153-6 - Use of Hepatitis A vaccine for post-exposure prophylaxis in adults >40 years of age
Linked from MMWR; November 1, 2018 / 67(43);1216-1220 - Use of Heplisav-B (HepB-CpG)
Linked from MMWR; April 20, 2018 / 67(15);455–458 - Use of Recombinant Zoster Vaccine (RZV) and Herpes Zoster Live-Attenuated Vaccine (ZVL)
Linked from MMWR; January 26, 2018 / 67(3);103-8 - Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps Disease Because of a Mumps Outbreak
Linked from MMWR; January 12, 2018 / 67(1);33–8 - Use of Cholera Lyophilized CVD 103-HgR Vaccine
Linked from MMWR; May 12, 2017 / 66(18);482-5 - Use of a 2-Dose Schedule for Human Papillomavirus Vaccination
Linked from MMWR; December 16, 2016 / 65(49);1405-8 - Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons
Linked from MMWR; November 4, 2016 / 65(43);1189-94 - Use of Smallpox Vaccine in Laboratory and Health-Care Personnel at Risk for Occupational Exposure to Orthopoxviruses
Linked from MMWR; March 18, 2016 / 65(10);257-62 - Use of Serogroup B Meningococcal (MenB) Vaccines in Adolescents and Young Adults (Including College Students)
Linked from MMWR; October 23, 2015 / 64(41);1171-6 - Use of Yellow Fever Vaccine Booster Doses
Linked from MMWR; June 19, 2015 / 64(23);647-650 - Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk for Serogroup B Meningococcal Disease
Linked from MMWR; June 12, 2015 / 64(22);608-612 - Use of 9-Valent Human Papillomavirus Vaccine (9vHPV) in Females and Males
Linked from MMWR; March 27, 2015 / 64(11);300-304 - Use of Pneumococcal Vaccines for Adults aged ≥65 years
Linked from MMWR; September 19, 2014 / 63(37);822-815 - Use of LAIV in children aged 2 through 8 years
Linked from MMWR; August 15, 2014 / 63(32);691-697 - Use of Japanese Encephalitis Vaccine in Children
Linked from MMWR; November 15, 2013 / 62(45);898-900 - Pneumococcal Vaccines for Immunocompromised Children
Linked from MMWR; June 28, 2013 / 62(25);521-524 - Infant Meningococcal Vaccines
Linked from MMWR; March 22, 2013 / 62(RR02);1-22 - Pneumococcal Vaccines for Immunocompromised Adults
Linked from MMWR; October 12, 2012 / 61(40);816-819 - Quadrivalent HPV Vaccine for Males
Linked from MMWR; December 23, 2011 / 60(50);1705-8 - Hepatitis B Vaccine in Adults with Diabetes
Linked from MMWR; December 23, 2011 / 60(50);1709-11
Page last reviewed: September 24, 2020
Content source: National Center for Immunization and Respiratory Diseases